Ingersoll Rand Beats Q3 Earnings Estimates, Raises Revenue Guidance

Zacks
Open on Zacks
Ingersoll Rand Beats Q3 Earnings Estimates, Raises Revenue Guidance

Ingersoll Rand Inc. IR reported third-quarter 2026 adjusted earnings of $1.07 per share, beating the Zacks Consensus Estimate of 89 cents by 20.2%. The bottom line increased 24.4% from the year-ago quarter.

Revenues of $2.06 billion surpassed the consensus estimate of $2.04 billion by 1.1% and rose 5.6% year over year. Organic revenues increased 3.9%, while acquisitions and favorable foreign currency movements contributed 1.4% and 0.3%, respectively.

IR's Orders and Organic Growth

In the third quarter of 2026, its total orders increased 20.7% to $2.35 billion. Organic orders increased 18.2% year over year. Acquisitions added 1.7% to order growth, while foreign currency translation contributed 0.8%.

Management noted an improved demand environment and healthy order momentum across short-to-medium-cycle and long-cycle businesses. The company recorded a book-to-bill ratio of 1.14, supported by an approximately $195 million order for a large-scale, mission-critical infrastructure project.

Segmental Performance

Industrial Technologies and Services generated revenues of $1.62 billion, up 5.2% year over year and accounting for about 78.5% of total revenues. Organic revenues increased 3.5%, with positive growth across all regions. Acquisitions and foreign currency added 1.2% and 0.5%, respectively. The segment recorded a book-to-bill ratio of 1.17, indicating strong order momentum.

The segment's adjusted EBITDA increased 6.3% to $475.7 million, while its margin expanded 40 basis points to 29.4%. Excluding IEEPA tariff refunds, adjusted EBITDA increased 0.7% to $450.8 million, while the margin contracted 120 basis points to 27.8%. Organic orders surged 22.1%, driven by strength in long-cycle projects and continued momentum in short-to-medium-cycle businesses.

Precision and Science Technologies recorded revenues of $444.9 million, up 7.3%. Organic revenues increased 5.5%, while acquisitions contributed 2.2%. Foreign currency had an unfavorable impact of 0.4%. Organic orders rose 4.2%, supported by low-double-digit growth in Life Sciences Technologies.

The segment's adjusted EBITDA increased 19.5% to $152.5 million. Its adjusted EBITDA margin expanded 350 basis points to 34.3%. Excluding IEEPA tariff refunds, adjusted EBITDA increased 13.7% to $145.1 million, while the margin expanded 180 basis points to 32.6%, reflecting strong operational execution.

Ingersoll Rand Inc. Price, Consensus and EPS Surprise

Ingersoll Rand Inc. Price, Consensus and EPS Surprise

Ingersoll Rand Inc. price-consensus-eps-surprise-chart | Ingersoll Rand Inc. Quote

Ingersoll Rand's Margin Profile

The company's total adjusted EBITDA increased 7.3% year over year to $584.4 million. The adjusted EBITDA margin expanded 40 basis points to 28.3%. Excluding IEEPA tariff refunds, adjusted EBITDA increased 1.4% to $552 million, while the margin contracted 120 basis points to 26.7%, primarily due to inflationary pressures.

In the quarter, IR's cost of sales increased 3.7% to $1.14 billion, while selling and administrative expenses rose 8% to $389.7 million. Adjusted net income increased to $416.6 million from $345.6 million, while the adjusted net income margin expanded to 20.2% from 17.7%.

Ingersoll Rand's Cash Flow and Liquidity

Cash provided by operating activities totaled $647.8 million in the third quarter, up from $354.6 million in the year-ago quarter. Capital expenditures declined to $24.5 million from $29.1 million, lifting free cash flow to $623.3 million from $325.5 million. The free cash flow margin improved to 30.2% from 16.6%.

IR ended the quarter with $3.9 billion in available liquidity, including $1.34 billion in cash and $2.6 billion of undrawn revolving credit capacity. The company paid dividends of $8 million and repurchased shares worth $350 million. It also deployed $90 million toward acquisitions.

Long-term debt (less current maturities) was $4.04 billion, lower than $4.78 billion recorded at the end of 2025. Net debt to adjusted EBITDA improved to 1.6 times from 1.8 times in the year-ago quarter.

IR's 2026 Outlook

Ingersoll Rand raised its 2026 revenue growth outlook to 5.5-7% from the previous projection of 4.5-6.5%. The forecast assumes organic growth of 2-3.5%, an approximately 1% currency benefit and a roughly 2.5% contribution from acquisitions.

The company maintained its adjusted EBITDA guidance of $2.13-$2.19 billion, excluding third-quarter IEEPA tariff refunds. Management raised its adjusted earnings forecast to $3.58-$3.70 per share from the previous range of $3.45-$3.57.

Free cash flow conversion is projected to exceed 100% of adjusted net income, including recoveries related to the ILC Dover transaction. Excluding these recoveries, free cash flow conversion is projected at approximately 95%.

IR’s Zacks Rank

The company currently carries a Zacks Rank #3 (Hold).  

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

 

Performance of Other Companies

In the third quarter of 2026, Graco Inc. GGG came out with quarterly earnings of $0.81 per share, missing the Zacks Consensus Estimate of $0.82 per share. This compares with earnings of $0.73 per share a year ago.

Graco reported revenues of $586.39 million in the quarter ended September 2026, missing the Zacks Consensus Estimate by 0.58%. This compares with year-ago revenues of $543.36 million.

Dover Corporation DOV has reported third-quarter 2026 adjusted earnings of $2.88 per share, rising 10% year over year and beating the Zacks Consensus Estimate of $2.83 by 1.77%. The improvement reflected broad-based demand, higher revenues and operational execution.

Revenues increased 7.5% year over year to $2.23 billion, beating the Zacks Consensus Estimate of $2.20 billion by 1.47%. Organic revenues grew 7.1%. Our model expected organic revenues to rise 4%.

Allegion plc ALLE reported third-quarter 2026 adjusted earnings of $2.60 per share, up 13% year over year. The figure beat the Zacks Consensus Estimate of $2.49 by 4.4%, supported by strong organic growth and margin expansion.

Revenues increased 9.6% year over year to $1.17 billion, beating the Zacks Consensus Estimate of $1.13 billion by 3.4%. Organic revenues grew 7.2%, driven by strength in the Americas non-residential business, volume growth and price realization.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Ingersoll Rand Inc. (IR): Free Stock Analysis Report
 
Dover Corporation (DOV): Free Stock Analysis Report
 
Graco Inc. (GGG): Free Stock Analysis Report
 
Allegion PLC (ALLE): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research